{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:23:57Z","timestamp":1790277837304,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00415-019-09225-z","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T02:50:58Z","timestamp":1549853458000},"page":"982-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7523-6956","authenticated-orcid":false,"given":"Roberto","family":"Massa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Testi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Rastelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolama A.","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Pompeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"9225_CR1","first-page":"23","volume-title":"Novel challenges in myasthenia gravis","author":"A Carr","year":"2015","unstructured":"Carr A (2015) Actual world epidemiology of myasthenia gravis. In: Mineo TC (ed) Novel challenges in myasthenia gravis. Nova Science Publisher Inc, New York, pp\u00a023\u201343"},{"key":"9225_CR2","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","volume":"257","author":"I Casetta","year":"2010","unstructured":"Casetta I, Groppo E, De Gennaro R et al (2010) Myasthenia gravis: a changing pattern of incidence. J Neurol 257:2015\u20132019","journal-title":"J Neurol"},{"key":"9225_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000336002","volume":"38","author":"C Montomoli","year":"2012","unstructured":"Montomoli C, Citterio A, Piccolo G et al (2012) Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy. Neuroepidemiology 38:100\u2013105","journal-title":"Neuroepidemiology"},{"key":"9225_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Str\u00f6bel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884","journal-title":"Autoimmun Rev"},{"key":"9225_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mus.23964","volume":"48","author":"NM Alkhawajah","year":"2013","unstructured":"Alkhawajah NM, Oger J (2013) Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing. Muscle Nerve 48:705\u2013710","journal-title":"Muscle Nerve"},{"key":"9225_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2119\/molmed.2015.00232","volume":"21","author":"MF Seldin","year":"2015","unstructured":"Seldin MF, Alkhairy OK, Lee AT et al (2015) Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations. Mol Med 21:769\u2013781","journal-title":"Mol Med"},{"key":"9225_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton AE, Pliner HA, Provenzano C et al (2015) A genome-wide association study of Myasthenia Gravis. JAMA Neurol 72:396\u2013404","journal-title":"JAMA Neurol"},{"key":"9225_CR8","first-page":"109","volume-title":"Novel challenges in myasthenia gravis","author":"K Poulas","year":"2015","unstructured":"Poulas K, Zagoriti Z, Kambpouris M, Lagoumintzis G (2015) Advanced Genetics in Myasthenia Gravis. In: Mineo TC (ed) Novel challenges in myasthenia gravis. Nova Science Publisher Inc, New York, pp\u00a0109\u2013132"},{"key":"9225_CR9","doi-asserted-by":"crossref","unstructured":"Testi M, Terracciano C, Guagnano A et al (2012) Association of HLA-DQB1*05:02 and DRB1*16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis. Autoimmune Dis 2012:541760","DOI":"10.1155\/2012\/541760"},{"key":"9225_CR10","doi-asserted-by":"crossref","unstructured":"Evoli A, Antonini G, Antozzi C et al (2019) Italian recommendations for the diagnosis and treatment of myasthenia gravis. Neurol Sci (in press)","DOI":"10.1007\/s10072-019-03746-1"},{"key":"9225_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.humimm.2013.06.020","volume":"74","author":"R Klein","year":"2013","unstructured":"Klein R, Marx A, Str\u00f6bel P, Schalke B, Nix W, Willcox N (2013) Autoimmune association and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis. Hum Immunol 74:1184\u20131193","journal-title":"Hum Immunol"},{"key":"9225_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3109\/08916934.2015.1031890","volume":"48","author":"A Evoli","year":"2015","unstructured":"Evoli A, Caliandro P, Iorio R et al (2015) Poly-autoimmunity in patients with myasthenia gravis: a single-center experience. Autoimmunity 48:412\u2013417","journal-title":"Autoimmunity"},{"key":"9225_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 65:928\u2013930","journal-title":"Neurology"},{"key":"9225_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-59745-156-7_9","volume-title":"Myasthenia gravis and related disorders","author":"MA Agius","year":"2009","unstructured":"Agius MA, Richman DP, Vincent A (2009) Autoantibody testing in the diagnosis and management of autoimmune disorders of neuromuscular transmission and related disorders. In: Kaminski HJ (ed) Myasthenia gravis and related disorders, 2nd\u00a0edn. Humana Press, New York, pp\u00a0143\u2013156","edition":"2"},{"key":"9225_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","volume":"305","author":"H Murai","year":"2011","unstructured":"Murai H, Yamashita N, Watanabe M et al (2011) Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci 305:97\u2013102","journal-title":"J Neurol Sci"},{"key":"9225_CR16","doi-asserted-by":"publisher","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","volume":"7","author":"AH Maniaol","year":"2012","unstructured":"Maniaol AH, Elsais A, Lorentzen AR et al (2012) Late Onset myasthenia gravis is associated with HLA DRB1*15:01 in the norwegian population. PLoS One 7:e36603","journal-title":"PLoS One"},{"key":"9225_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmunity 48\u201349:143\u2013148","journal-title":"J Autoimmunity"},{"key":"9225_CR18","doi-asserted-by":"publisher","first-page":"e106757","DOI":"10.1371\/journal.pone.0106757","volume":"9","author":"T Akaishi","year":"2014","unstructured":"Akaishi T, Yamaguchi T, Suzuki Y et al (2014) Insights into the classification of Myasthenia gravis. PloS ONE 9:e106757","journal-title":"PloS ONE"},{"key":"9225_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","volume":"505","author":"FM Howard Jr","year":"1987","unstructured":"Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR (1987) Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in Myasthenia gravis. Ann N Y Acad Sci 505:526\u2013538","journal-title":"Ann N Y Acad Sci"},{"key":"9225_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10072-015-2236-8","volume":"36","author":"SY Kang","year":"2015","unstructured":"Kang SY, Oh JH, Song SK, Lee JS, Choi JC, Kang JH (2015) Both binding and blocking antibodies correlate with disease severity in myasthenia gravis. Neurol Sci 36:1167\u20131171","journal-title":"Neurol Sci"},{"key":"9225_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.02.004","volume":"210","author":"C Vandiedonck","year":"2009","unstructured":"Vandiedonck C, Raffoux C, Eymard B et al (2009) Association of HLA-A in autoimmune Myasthenia gravis with thymoma. J Neuroimmunol 210:120\u2013123","journal-title":"J Neuroimmunol"},{"key":"9225_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","volume":"72","author":"E Bartoccioni","year":"2009","unstructured":"Bartoccioni E, Scuderi F, Augugliaro A et al (2009) HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. Neurology 72:195\u2013197","journal-title":"Neurology"},{"key":"9225_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.12525","volume":"22","author":"AV Nikolic","year":"2015","unstructured":"Nikolic AV, Andric ZP, Simonovic RB et al (2015) High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis. Eur J Neurol 22:59\u201363","journal-title":"Eur J Neurol"},{"key":"9225_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1749-6632.1998.tb10946.x","volume":"841","author":"F Baggi","year":"1998","unstructured":"Baggi F, Antozzi C, Andreetta F et al (1998) Identification of a novel HLA class II association with DQB1\u22170502 in an Italian myasthenic population. Ann N Y Acad Sci 841:355\u2013359","journal-title":"Ann N Y Acad Sci"},{"key":"9225_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","volume":"166\u2013167","author":"G Saruhan-Direskeneli","year":"2016","unstructured":"Saruhan-Direskeneli G, Hughes T, Yilmaz V et al (2016) Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clin Immunol 166\u2013167:81\u201388","journal-title":"Clin Immunol"},{"key":"9225_CR26","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.1007\/s00253-017-8557-1","volume":"101","author":"BV Ayyar","year":"2017","unstructured":"Ayyar BV, Atassi MZ (2017) Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis. Appl Microbiol Biotechnol 101:8165\u20138179","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09225-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:08:05Z","timestamp":1581361685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09225-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["9225"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09225-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol was approved by the Independent Ethic Committee of PTV and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"All participating subjects signed an informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}